These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4539940)

  • 1. Failure of dipyridamole (Persantin) in reducing the infarct size following experimental coronary occlusion.
    Watanabe T; Shintani F; Fu L; Kato K; Koyama S
    Jpn Heart J; 1972 Nov; 13(6):512-20. PubMed ID: 4539940
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of vasodilation through dipyridamole on the extent of acute experimental infarct].
    Bleifeld W; Wende W; Meyer J; Bussmann WD
    Z Kardiol; 1974 Feb; 63(2):115-28. PubMed ID: 4409852
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of inhibition of lipolysis on heart failure following acute coronary occlusion in the dog.
    Kjekshus JK
    Cardiovasc Res; 1974 Jan; 8(1):73-80. PubMed ID: 4819492
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of the size of acute, experimental myocardial infarction by Verapamil.
    Wende W; Bleifeld W; Meyer J; Stühlen HW
    Basic Res Cardiol; 1975; 70(2):198-208. PubMed ID: 1137560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction.
    Roberts AJ; Jacobstein JG; Cipriano PR; Alonso DR; Combes JR; Gay WA
    Circulation; 1980 Feb; 61(2):228-36. PubMed ID: 7351049
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of nitroglycerin and dipyridamole on acute myocardial infarction: a thermographic study in the dog.
    Malm A; Arborelius M; Lilja B; Gil RL; Bornmyr S
    Cardiovasc Res; 1979 May; 13(5):281-7. PubMed ID: 113100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial reactive hyperaemia in conscious dogs: effect of dipyridamole and aminophylline on responses to four- and eight-second coronary artery occlusions.
    Eikens E; Wilcken DE
    Aust J Exp Biol Med Sci; 1973 Oct; 51(5):617-30. PubMed ID: 4787501
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced changes in blood flow in the acutley ischaemic canine myocardium;relationship to subendocardial driving pressure.
    Marshall RJ; Parratt JR
    Clin Exp Pharmacol Physiol; 1974; 1(2):99-112. PubMed ID: 4458991
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic effects of dipyridamole (Persantin) following beta-blockade in coronary failure].
    Kinsbergen M; Friedemann M
    Schweiz Med Wochenschr; 1973 Feb; 103(8):312-5. PubMed ID: 4144418
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of pinacidil on myocardial blood flow and infarct size after acute left anterior descending coronary artery occlusion and reperfusion in awake dogs with and without a coexisting left circumflex coronary artery stenosis.
    Sakamoto S; Liang CS; Stone CK; Hood WB
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):747-55. PubMed ID: 2481189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium.
    Ledingham IM; Marshall RJ; Parratt JR
    Br J Pharmacol; 1973 Mar; 47(3):626P-627P. PubMed ID: 4730845
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of noradrenaline on blood flow and oxygen consumption in normal and ischemic areas of myocardium.
    Marhsall RJ; Parratt JR
    Am Heart J; 1973 Nov; 86(5):653-62. PubMed ID: 4743334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE EFFECT OF PERORAL LONG-TERM TREATMENT WITH PERSANTIN IN DOGS ON CORONARY BLOOD FLOW DURING REST, AFTER NORADRENALIN AND ON THE SURVIVAL TIME OF THE HEART FOLLOWING TOTAL AORTA LIGATION].
    NEUHAUS G; NASSERI M; FIEDLER E; SEKI I
    Z Gesamte Exp Med; 1963 Dec; 137():574-86. PubMed ID: 14124498
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of carbocromen and of other coronary dilator agents on the blood flow of a myocardial ischemic area].
    Faucon G; Ollagnier M; de Claviere M; Kofman J; Evreux JC
    Therapie; 1975; 30(2):185-95. PubMed ID: 1162641
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dipyridamole on myocardial clearance of Rb86 and on some parameters of central hemodynamics in man without coronary arterial disease.
    De Ponti C; Bardi U
    Am Heart J; 1971 Jul; 82(1):69-77. PubMed ID: 5581722
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of quazodine on myocardial blood flow in developing myocardial infarcts.
    Parratt JR; Winslow E
    J Pharm Pharmacol; 1971 Dec; 23():224S-225S. PubMed ID: 4401475
    [No Abstract]   [Full Text] [Related]  

  • 18. [Screening of substances with coronary vasodilator action].
    Lenke D
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oxygen pressure and oxygen consumption in coronary venous blood as well as the changes of the arterio-coronary venous O2 content difference and the coronary circulation with high doses of 2,6-(diethanolamino)-4,-8-dipiperidinopyrimido -(5,4-d) pyrimidine (Persantin)].
    Doll E; Keul J; Brechtel
    Z Kreislaufforsch; 1966 Nov; 55(10):1076-97. PubMed ID: 5998956
    [No Abstract]   [Full Text] [Related]  

  • 20. [Coronary circulation. 2. Coronary resistance, (3) propranolol (Indersal), (4) dipyridamole (Persantin) and vasopressin (Pitressin)].
    Saito T
    Masui; 1972 May; 21(5):479-86. PubMed ID: 4561562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.